RxDoctor Payments Data

Deborahlin Huxtable, APRN

Psychiatric/Mental Health · Fort Myers, FLNPI 1477069516

Payments from drug & device makers

$4,041in general payments, 2019–2025

Across 232 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$657
  • Neurocrine Biosciences, Inc.$379
  • Ironshore Pharmaceuticals Inc.$342
  • Corium, LLC$324
  • Teva Pharmaceuticals USA, Inc.$317
  • Otsuka America Pharmaceutical, Inc.$305
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$3,99299%
  • Education$491%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,041 in reported general payments places this provider in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$27,597
Medicare patients
73
Services billed
317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole15$46,321
VraylarCariprazine Hcl31$44,919
CaplytaLumateperone Tosylate19$31,485
Buspirone Hcl204$4,632
Desvenlafaxine Succinate ErDesvenlafaxine Succinate98$4,161
Quetiapine Fumarate209$3,249
Ziprasidone Hcl34$2,765
Duloxetine Hcl98$2,396
Hydroxyzine Hcl103$1,881
Vilazodone Hcl12$1,727
Aripiprazole29$1,620
Lamotrigine155$1,527
Trazodone Hcl168$1,399
Lurasidone Hcl30$1,281
Oxcarbazepine23$1,075

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$305$46,32115 claims
AbbVieVraylar$657$44,91931 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$281$31,48519 claims
Almatica Pharma LLCSertraline Hcl$105$93592 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →